FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2014085232> ?p ?o ?g. }

• W2014085232 endingPage "68" @default.
• W2014085232 startingPage "63" @default.
• W2014085232 abstract "Expression of both P-glycoprotein (P-gp) and mutant p53 have recently been reported to be associated with poor prognosis of breast cancer. The expression of P-gp is associated in vitro and in vivo with cross-resistance to several anti-cancer drugs. p53 plays a regulatory role in apoptosis, and mutant p53 has been suggested to be involved in drug resistance. Interestingly, in vitro experiments have shown that mutant p53 can activate the promoter of the MDR1 gene, which encodes P-gp. We investigated whether p53 and P-gp are simultaneously expressed in primary breast cancer cells and analysed the impact of the co-expression on patients prognosis. Immunohistochemistry was used to investigate P-gp expression (JSB-1, C219) and nuclear p53 accumulation (DO-7) in 20 operable chemotherapy untreated and 30 locally advanced breast cancers undergoing neoadjuvant chemotherapy with doxorubicin and cyclophosphamide. Double immunostaining showed that P-gp expression and nuclear p53 accumulation often occur concomitantly in the same tumour cells. A correlation between p53 and P-gp expression was found in all 50 breast cancers (P = 0.003; Fisher's exact test). P-gp expression, nuclear p53 accumulation, and co-expression of p53 and P-gp were more frequently observed in locally advanced breast cancers than in operable breast cancers (P = 0.0004, P = 0.048; P = 0.002 respectively. Fisher's exact test). Co-expression of p53 and P-gp was the strongest prognostic factor for shorter survival by multivariate analysis (P = 0.004) in the group of locally advanced breast cancers (univariate analysis: P = 0.0007). Only 3 out of 13 samples sequentially taken before and after chemotherapy displayed a change in P-gp or p53 staining. In conclusion, nuclear p53 accumulation is often associated with P-gp expression in primary breast cancer, and simultaneous expression of p53 and P-gp is associated with shorter survival in locally advanced breast cancer patients. Co-expression of P-gp and mutant p53 belong to a series of molecular events resulting in a more aggressive phenotype, drug resistance and poor prognosis." @default.
• W2014085232 created "2016-06-24" @default.
• W2014085232 creator A5015590714 @default.
• W2014085232 creator A5022063365 @default.
• W2014085232 creator A5045348834 @default.
• W2014085232 creator A5062035206 @default.
• W2014085232 creator A5084438796 @default.
• W2014085232 creator A5086717130 @default.
• W2014085232 date "1996-07-01" @default.
• W2014085232 modified "2023-10-16" @default.
• W2014085232 title "p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer" @default.
• W2014085232 cites W1490707610 @default.
• W2014085232 cites W1552426876 @default.
• W2014085232 cites W1968833980 @default.
• W2014085232 cites W1978089940 @default.
• W2014085232 cites W1978342483 @default.
• W2014085232 cites W1978718921 @default.
• W2014085232 cites W1979319210 @default.
• W2014085232 cites W1990714585 @default.
• W2014085232 cites W2002259547 @default.
• W2014085232 cites W2016409260 @default.
• W2014085232 cites W2037705779 @default.
• W2014085232 cites W2041209857 @default.
• W2014085232 cites W2060358859 @default.
• W2014085232 cites W2060937867 @default.
• W2014085232 cites W2076149108 @default.
• W2014085232 cites W2081894694 @default.
• W2014085232 cites W2082178094 @default.
• W2014085232 cites W2093422551 @default.
• W2014085232 cites W2111703821 @default.
• W2014085232 cites W2139330198 @default.
• W2014085232 cites W2139984188 @default.
• W2014085232 cites W2142058281 @default.
• W2014085232 cites W2161663775 @default.
• W2014085232 cites W2272221901 @default.
• W2014085232 cites W267182146 @default.
• W2014085232 doi "https://doi.org/10.1038/bjc.1996.316" @default.
• W2014085232 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2074603" @default.
• W2014085232 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8679460" @default.
• W2014085232 hasPublicationYear "1996" @default.
• W2014085232 type Work @default.
• W2014085232 sameAs 2014085232 @default.
• W2014085232 citedByCount "92" @default.
• W2014085232 countsByYear W20140852322012 @default.
• W2014085232 countsByYear W20140852322013 @default.
• W2014085232 countsByYear W20140852322014 @default.
• W2014085232 countsByYear W20140852322015 @default.
• W2014085232 countsByYear W20140852322016 @default.
• W2014085232 countsByYear W20140852322017 @default.
• W2014085232 countsByYear W20140852322018 @default.
• W2014085232 countsByYear W20140852322019 @default.
• W2014085232 countsByYear W20140852322020 @default.
• W2014085232 countsByYear W20140852322021 @default.
• W2014085232 countsByYear W20140852322022 @default.
• W2014085232 countsByYear W20140852322023 @default.
• W2014085232 crossrefType "journal-article" @default.
• W2014085232 hasAuthorship W2014085232A5015590714 @default.
• W2014085232 hasAuthorship W2014085232A5022063365 @default.
• W2014085232 hasAuthorship W2014085232A5045348834 @default.
• W2014085232 hasAuthorship W2014085232A5062035206 @default.
• W2014085232 hasAuthorship W2014085232A5084438796 @default.
• W2014085232 hasAuthorship W2014085232A5086717130 @default.
• W2014085232 hasBestOaLocation W20140852322 @default.
• W2014085232 hasConcept C114851261 @default.
• W2014085232 hasConcept C121608353 @default.
• W2014085232 hasConcept C126322002 @default.
• W2014085232 hasConcept C133936738 @default.
• W2014085232 hasConcept C142724271 @default.
• W2014085232 hasConcept C143998085 @default.
• W2014085232 hasConcept C191093355 @default.
• W2014085232 hasConcept C204232928 @default.
• W2014085232 hasConcept C2776694085 @default.
• W2014085232 hasConcept C2776755627 @default.
• W2014085232 hasConcept C2778707650 @default.
• W2014085232 hasConcept C2781303535 @default.
• W2014085232 hasConcept C4224716 @default.
• W2014085232 hasConcept C502942594 @default.
• W2014085232 hasConcept C530470458 @default.
• W2014085232 hasConcept C71924100 @default.
• W2014085232 hasConcept C86803240 @default.
• W2014085232 hasConcept C89423630 @default.
• W2014085232 hasConceptScore W2014085232C114851261 @default.
• W2014085232 hasConceptScore W2014085232C121608353 @default.
• W2014085232 hasConceptScore W2014085232C126322002 @default.
• W2014085232 hasConceptScore W2014085232C133936738 @default.
• W2014085232 hasConceptScore W2014085232C142724271 @default.
• W2014085232 hasConceptScore W2014085232C143998085 @default.
• W2014085232 hasConceptScore W2014085232C191093355 @default.
• W2014085232 hasConceptScore W2014085232C204232928 @default.
• W2014085232 hasConceptScore W2014085232C2776694085 @default.
• W2014085232 hasConceptScore W2014085232C2776755627 @default.
• W2014085232 hasConceptScore W2014085232C2778707650 @default.
• W2014085232 hasConceptScore W2014085232C2781303535 @default.
• W2014085232 hasConceptScore W2014085232C4224716 @default.
• W2014085232 hasConceptScore W2014085232C502942594 @default.
• W2014085232 hasConceptScore W2014085232C530470458 @default.
• W2014085232 hasConceptScore W2014085232C71924100 @default.
• W2014085232 hasConceptScore W2014085232C86803240 @default.

• next